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Human Health Effects of Fatty Acids in Beef1
Marcela S. Whetsell, WVU Division of Plant Science
Edward B. Rayburn and John D. Lozier, WVU Extension Service
The popular perception of fats is that they not
only make you fat, but they also increase the risk of
a number of health problems such as heart diseases, stroke, diabetes, and some cancers. However, fats are essential to human health. To date
numerous reports have been written describing the
influence of dietary fats on humans and animals.
The objective of this paper is to describe the importance of individual fatty acid on human health.
The white material called fat on a cut of meat is
adipose tissue. This adipose tissue is a form of
connective tissue, which functions to surround adipose cells that serve as heat insulators and reserve
energy supplies (Allen, 1976). These adipose cells
are distended with lipids, water, and other constituents. Lipids will constitute 80% to 90% of the volume of adipose tissue in finished beef animals.
Five to 15% is water and the remainder is protein,
minerals, and carbohydrates. However, such proportions vary with stage of growth and state of nutritional change in the animal (Allen, 1976).
Often the terms "fat" and "lipid" are used interchangeably. Speaking, in a strict chemical sense,
the term "fat" refers to lipids, which are the major
components of adipose tissue. Fatty acids are a
type of lipid.
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chain and carries the maximum number of hydrogen atoms. The number following the colon that
refers to the length of the carbon chain indicates the
degree of saturation. Thus, C12:0 refers to a fatty
acid with 12 carbon atoms and no double bonds (a
saturated fatty acid). When unsaturation occurs,
one or more hydrogen atoms are removed and a
double bond between two carbons is formed (C=C).
For instance, C16:1 represents a monounsaturated
fatty acid composed of 16 carbons with 1 unsaturation point (removal of two hydrogen atom; mono
means one), while C18:3 represents a polyunsaturated fatty acid composed of 18 carbons with 3 unsaturation points (removal of 6 hydrogen atoms,
poly means many).
Both number and location of the double bond are
important for a fatty acid’s biological function and
stability. For instance, saturation increases stability.
Fats can become oxidized or rancid when exposed
to oxygen. Polyunsaturated fatty acids spoil because the double bonds are unstable. Saturated
fats are more resistant to oxidation and thus less
likely to become rancid.
When double bonds are present, the fatty acids
may be present in either a cis- or trans- configuration, giving different shapes to the fatty acid.

A fatty acid is a chain of carbon atoms with hydrogen atoms attached. The first obvious classification of fatty acids is by carbon chain length, which
may range from one (C1) to 30 (C30) carbon atoms.
For instance, C12 represents a fatty acid with 12
carbon atoms.
Fatty acids of C1 to C6 length exist in a free form.
The longer carbon chain fatty acids can exist in a
free form or esterified as triglyceride (3 fatty acids
bound to a glyceride molecule). Fatty acids located
within the adipose tissue in ruminants occur almost
entirely as triglycerides with a predominance of C16
and C18 fatty acids.
Fatty acids may be saturated, monounsaturated,
or polyunsaturated. A saturated fatty acid is a
molecule that has no double bonds in the carbon
1

Fig.1
Shown above is the essential fatty acid, alphalinolenic acid (C18:3 cis) (the notation C18:3 tells us
that the fatty acids has 18 carbons in the carbon
chain and 3 points of unsaturation due to 3 points
between carbon atoms with double bonds). Note
that at the double bonds, the missing hydrogen atoms all come from one side. This is the cis- configuration (18:3 cis). Unsaturated fatty acids rarely

This fact sheet is a product of the "Pasture-Based Beef Systems for Appalachia" project, a multi-institutional collaboration among West Virginia University,
U. S. Department of Agriculture's Agricultural Research Service, and Virginia Tech.

Fig.2
appear in the trans-form in nature, except in small
amounts in ruminant products (dairy, beef). However, when unsaturated fatty acids are overheated
as in industry, the hydrogen atoms can jump from
side to side. This is most commonly found in partially hydrogenated vegetables oils. The picture below shows alpha-linolenic acid in its transconfiguration (C18:3 trans).
The gray Hs in the above illustration show where
the hydrogen atoms were before heating. The black
Hs show the spots they moved into. Notice that they
flipped sides. Even though the same number of carbon and hydrogen atoms is in the molecule, this is
not at all the same fatty acid. Because there is now
a balanced number of hydrogen atoms on each side
of the molecule, it no longer bends, but is straight,
like a saturated fatty acid. Also, its melting point
has risen dramatically. In our bodies, it acts more
like a saturated fatty acid than an unsaturated fatty
acid. Most trans-fatty acids do not have beneficial
properties compared to cis-fatty acids.
Saturated fatty acids are the main fatty acids
found in meat and dairy products. Unsaturated fats
are most commonly found in the oils of vegetables,
such as avocado, and also in nuts and fish. Unsaturated fats are considered the healthiest dietary fats.
Another classification of fats is the "essential fatty
acids". These are the polyunsaturated fatty acids
that cannot be produced in the human body and
must be obtained from the diet, since they are
needed for basic functions in our bodies. Present in
every healthy cell of the body, they are critical for
normal growth and functioning of the cells, muscles,
nerves, and organs. Deficiency of essential fatty acids is linked to a variety of symptoms including
rough and scaly skin and dermatitis (omega-6 fatty
acid) and scaly and hemorrhagic dermatitis, hemorrhagic follicilitis of the scalp, impaired wound healing
and growth retardation (omega-3 fatty acids). Adequate intakes of essential fatty acids may protect
against heart diseases and diabetes (DRI, 2002). It
has been estimated that as much as 50% of the
American population may consume insufficient
quantities of essential fatty acids (Hu et al., 1999).

There are two types of essential fatty acids important to human health – the omega-6 and the omega3 fatty acids. The term "omega" refers to the position of the first double bond in the fatty acid, counting from the methyl end (O=C—OH) of the carbon
chain. An omega-3 fatty acid has the first double
bond on the third carbon atom, and an omega-6
fatty acid has the first double bond on the sixth carbon atom. Omega-3 and omega-6 fatty acids cannot
be converted from one form to the other. Both have
to be present in the diet in a proper balance for a
good health.
The metabolism of omega-6 and omega-3 fatty
acids in our bodies requires the same enzymes system, resulting in competition between the two families. An excess of one family of fatty acids (usually
omega-6) can interfere with the metabolism of the
other (usually omega-3), reducing the production of
omega-3-derived long-chain fatty acids, and altering
their biological effects (Horrobin and Manku, 1990;
Emken, 1995). For instance, linoleic (C18:2;
omega-6) and alpha-linolenic (C18:3; omega-3) fatty
acids are both essential to humans. From these
fatty acids, enzymes in the body can produce other,
longer chain fatty acids such as arachidonic acid
(AA, C20:4) omega-6, and docosahexaenoic acid
(DHA, 22:6) and eicosapentaenoic acid (EPA,
C20:5) omega-3, respectively. These two fatty acids
work together in a competitive balance to regulate
blood clotting, immune response, and inflammatory
processes. The AA fatty acid aids in the constriction
of blood vessels and the formation of blood clots,
and EPA aids in the relaxation of blood vessels and
inhibits blood clotting. Although they have opposite
functions, both are necessary to maintain a healthy
balance between excessive bleeding and excessive
blood clotting (Clandinin, 2000).
With changes in food production and diet, the
consumption of omega-6 has risen in this country
while omega-3 consumption has fallen. Ideally, intake of omega-6 fatty acids should be no more than
10 times that of omega-3 fatty acids (DRI, 2002),
some believe it should be even lower at 4:1
(Simopoulos, 1999). Today in the typical U.S. diet,
omega-6 intake is up to 20-30 times more than
omega-3 intake (Simopoulos, 1999).

About 80% of the fatty acid in beef is composed
of palmitic (C16:0), stearic (C18:0), and oleic acid
(C18:1). The remaining 20% is distributed among
30 different fatty acids. Inference of the health effect of fatty acids is based on experimental diets
enriched with selected fatty acids.
Oleic acid (C18:1) is the primary monounsaturated fatty acid in beef and accounts for
about 33% of the fatty acid in beef. It is also found
in rich amounts in olive, canola, and peanut oils.
Available evidence indicates that while most saturated fatty acids raise serum cholesterol concentrations the monounsaturated oleic acid does not
(Denke, 1994). For practical purposes, it is convenient to use the neutrality of oleic acid as a baseline
with which to judge the responses of other fatty acids. The fact that the body synthesizes a large
quantity of oleic acid suggests that it has a variety
of biological uses, and to this extent the concept of
the neutrality of oleic can be extended to imply
safety (Grundy, 1994). In several studies on the
relative carcinogenicity of fatty acids or their ability
to suppress the immune system, oleic acid was the
fatty acids with the least negative effect (Grundy,
1994). One reason why oleic acid may not raise serum cholesterol concentrations is because it is a
favored substrate for the liver enzyme that converts cholesterol to an inactive form (the Acyl CoA transferase:
cholesterol acyltransferase) (Grundy, 1994).

Palmitic acid (C16:0) is a saturated fatty acid accounting for about 27% of the fatty acids in beef.
There is very strong evidence that palmitic acid
raises serum cholesterol levels (Grundy, 1994) and
that this occurs predominantly by increasing bad
cholesterol (LDL) levels. This fatty acid accounts for
most of the cholesterol-raising activity from beef,
thereby increasing the risk of atherosclerosis, cardiovascular disease, and stroke (Nicolosi et al.,
1998).
Stearic acid (18:0) is a saturated fatty acid accounting for about 18% of the fatty acid in beef.
Several studies have shown that the stearic acid
effect on total cholesterol is minimal and not detrimental to human health (Bonanome et al., 1988;
Zock et al., 1992; Kris-Etherton et al., 1993; Judd et
al., 2002). For practical purposes, stearic acid is
essentially neutral in its effects on serum total cholesterol, similar to oleic acid (Grundy, 1994). It is
not clear why stearic acid does not raise cholesterol
level as do other saturated fatty acids. A possible
reason could be that it is rapidly absorbed into body
tissue compared with other saturated fatty acids
(Grundy, 1994). However, it has been observed in
dogs, rats, and hamsters that stearic acid or stearic
acid-rich glycerides are absorbed less efficiently

than saturated fatty acids of shorter chain length or
their glycerides (Kitchevsky, 1994). Some investigators have speculated that stearic acid may be
thrombogenic (causes blood clotting). This effect
has not been proven (Grundy, 1994). Also, the effects of stearic acid on hypertension, cancer, obesity, and other illnesses are unknown (Hu et al.,
1999).
Beef is also a source of two saturated fatty acids,
lauric (C12:0) and myristic (C14:0), that are related
to human health issues. Lauric and myristic fatty
acids are responsible for raising bad cholesterol
levels in blood serum (Grundy, 1994) and have
been shown to be strongly correlated with early
heart attack (Kromhout et al., 1995). However, the
percentages of lauric (less than 1%) and myristic (23%) acids in beef are small. Data suggest that lean
beef has no more cholesterol-raising effect than
chicken or fish and therefore, lean beef need not to
be eliminated from cholesterol-lowering diets
(Denke, 1994).
Fatty acids with an odd number of carbon atoms
such as pentadecanoic (C15:0) and heptadecanoic
acid (C17:0) (less than 1% and 1-2% of fatty acids
in beef respectively), are produced primarily from
accumulation of a 3-carbon fatty acid end product
that occurs due to the lack of vitamin B12. Oddchain fatty acids can build up in membrane lipids of
nervous tissue, resulting in altered myelin integrity
and demyelination, leading eventually to impaired
nervous system functioning (Frenkel et al., 1973).
Elaidic acid (C18:1) (2-5% of the fatty acid in
beef), is a monounsaturated trans-fatty acids, which
can raise bad cholesterol (LDL) in serum (Abbey
and Nestel, 1994; Muller et al., 1999, Judd et al.,
2002). Trans-fatty acids, as mention above, may
behave similar to saturated fatty acids. Studies
have shown that foods enriched in C18:1-trans resulted in higher bad cholesterol (LDL) levels compared with C18:1-cis (Nicolosi, et al., 1998; Judd et
al., 2002). Whereas C18:1-trans raised bad cholesterol (LDL) equivalent to saturated fatty acids, it had
no effects on good cholesterol (HDL) (Judd et al.,
2002).
Other monosaturated fatty acids are palmitoleic
acid (C16:1) (about 2%-3%), transvaccenic acid
(C18:1 trans-11) (3%-4%), and vaccenic acid
(C18:1 cis-11) (1-2%). Transvaccenic acid is important in the human bodies’ production of conjugated
linolenic acids (CLA) which is discussed later.
Palmitoleic acid (C16:1 cis) is a mono-unsaturated
fatty acid also found in rich amounts in macadamia
nuts, olive, canola, and peanut oils. This monounsaturated fatty acid is beneficial in reducing bad
cholesterol (LDL) and it behaves like a saturated

and not as a unsaturated fatty acid in its effect on
LDL cholesterol (Nestel et al., 1994). It also reduces
the fat deposition in blood vessels and reduces
blood clot formation (Grundy, 1994). Vaccenic acid
has no known importance to human health. However, all these C:18 fatty acids may be elongated
and desaturated in adipose tissue to produce long
chain fatty acids (C22 and C20), which are beneficial for human health (Burdge and Wootton, 2002).
The major important polyunsaturated fatty acids
found in beef are linoleic acid (C18:2) (about 3.5%),
alpha-linolenic acid (C18:3) (1.5%), arachidonic
acid (C20:4) (about 1%), eicosapentaenoic acid
(EPA) (C20:5) (<1%), docosanpetaenoic acid (DPA3) (C22:5) (<1%), and docosahexaenoic acid (DHA)
(C22:6) (<1%) (Enser et al., 1998). Alpha-linolenic
acid (C18:3) is classified as a short-chain omega-3
fatty acid and is also found in nuts and seeds. Eicosapentaenoic acid (EPA), docosapetaenoic acid
(DPA-3), and docosahexaenoic (DHA) are found
predominantly in foods of marine origin and are
classified as long-chain omega-3 fatty acids. The
meat and milk of grazing animals has been reported
to contain significantly more omega-3 fatty acids
than does meat and milk of animals fed conserved
forages and grains. This higher content of omega-3
fatty acids may be beneficial to human health (Kelly
et al., 1988; Dhiman, 1999).
Linoleic acid (C18:2) (about 3.5%) is also found
in corn, sunflower oil, safflower oil and soybeans.
Arachidonic acid (C20:4) (about 1%) is found in
brain, liver, glandular and egg lipids. Both of these
fatty acids belong to the omega-6 family of fatty acids.
The omega-3 fatty acids present in pastures, like
the alpha-linolenic acid (C18:3), appear to have little
direct value for human health. However, the human
body can add 2 or 4 carbons to these 18-carbon
chains fats to produce 20- or 22-carbon chain
omega-3 fatty acid. Thus, alpha-linolenic acid
(C18:3) is a precursor for EPA (C20:5) and DHA
(C22:6) fatty acids, which are important for human
health. It has been suggested that alpha-linolenic
acid has a beneficial effect on cardiovascular heart
disease (Ascherio et al., 1999; Hu et al., 1999).
However, other studies reported no evidence of alpha-linolenic acid having a positive effect on cardiovascular heart disease (Renaud et al., 2002; Sanderson et al., 2002). Although alpha-linolenic acid
suplementation causes an increase in the blood and
plasma levels of alpha-linolenic acid, EPA and DPA,
no benefit has shown on either risk factors for cardiovascular diseases or on the secondary prevention of cardiovascular heart disease (Sanderson et
al, 2002). More studies have to be done to deter-

mine alpha-linolenic acid beneficial effects on human health. Alpha-linolenic acid (C18:3) may help
balance linoleic acid (C18:2) and be beneficial
(Baer, 2003 personal communication).
For many years linoleic acid (C18:2; omega-6)
was thought to be the preferable fatty acid for the
diet because it was considered to be the most effective cholesterol-lowering fatty acid. However, despite an increase in linoleic acid intake (from about
4% to 7%), there has been a growing reservation
about recommending its consumption, due to no
proven long-term safety (Grundy, 1994). In humans,
high supplemental intakes of linoleic fatty acids can
lower good cholesterol concentration and may increase the risk for cholesterol gallstones. In addition, the presence of linoleic acid in bad cholesterol
lipids makes them more prone to oxidation, which
could promote atherosclerosis. Because of these
detrimental effects, current recommendations have
been moderated and now caution that intakes of
this fatty acid should not exceed current concentrations (about 7% of total energy intake) (Grundy,
1994). Surprisingly, recent information from the
American Heart Association indicates that linoleic
acid has a noticeable effect on lowering cholesterol
further than oleic and palmitic acids when plasma
cholesterol levels are high (>200 mg/dL). They suggest that at a 10 % calorie intake in the form of polyunsaturated fats, linoleic acid achieves a maximal
effect on cholesterol lowering. It also has been suggested (Iso et al., 2002) that a higher intake of linoleic acid appear to protect against stroke, possibly through potential mechanism of decreased
blood pressure, reduced platelet aggregation, and
enhance deformability of erythrocyte cells. More
studies need to be done to determine the effect of
linoleic acid in human health.
Linoleic acid (C18:2; omega-6) and alphalinolenic acid (C18:3; omega-3), are plant fatty acids
that can be transformed to CLA (conjugate linolenic
acid) by bacteria in the rumen (Kepler et. al. 1966).
CLA is a collective term describing a mixture of positional and conjugated isomers of linoleic acid
(C18:2) involving a double bond at positions 8 and
10, 9 and 11, 10 and 12, or 11 and 13 (Eulitz et al.,
1999). Each of these positional C18 isomers can
occur in cis-trans, trans-cis, cis-cis, and trans-trans
forms (Eulitz et al., 1999). In beef and milk samples, the cis 9–trans 11 and the cis10-trans12 CLA
are the predominant forms. Interest in CLA research has increased in the past few years as a result of reports of CLA consumption providing several health benefits (Kramer, 1998)). Because
plants do not synthesize CLA, ruminant fats in milk
or meat are the primary dietary CLA sources for humans (Herbein et al., 2000). The predominant CLA

in ruminant fats is the cis-9, trans-11 isomer that
accounts for more than 80% of total CLAs (Chin et
al., 1992). It has been found that CLA is an antioxidant, which also reduces circulating cholesterol in
mice (West et al., 1998). Other literature reports
that CLA has a positive effect by reducing cardiovascular risk, protects against atherosclerosis, is
anti-carcinogenic, reduces intake, reduces body
content of adipose tissue and lipid, and enhances
the immune system (Lee et. al., 1994; Nicolosi et
al., 1997; Ip et al.,, 1991, 1994; West et al, 1998;
Cook, 1991).
The CLA (C18:2 trans10, cis12) appears in
smaller quantity and seems to be involved in reduction of fatty acids synthesis in cows and mice
(Griinari et al., 1998; Park et al., 1999). However,
no direct effect of this CLA on human health has
been observed. French and co-workers (2000) reported that decreasing the proportion of concentrate
(grain) in the diet, which effectively increased grass
intake, causes a linear increase in CLA concentrations in intramuscular fat in steers.
It has been found that stearic acid (C18:0) cannot
be stored well in tissue. It is converted to oleic acid
(cis-18:1) apparently so body fat can be maintained
in a “liquid state” at body temperature (Herbein et
al., 2000). The enzyme that adds a double bond to
stearic acid to form oleic acid is SCD (stearoyl-CoA
desaturase or ∆9-desaturase). Most tissues of ruminants, mice, rat, and chicken, have SCD, especially
in the intestines, liver, adipose tissue, and mammary glands. This enzyme has also been detected
in humans. However, the distribution of SCD in humans is unknown. In humans, the liver is the principal tissue containing SCD and presumably also has
the highest SCD activity (Turpeinen et al., 2001).
SCD is important because it can add a cis-9 double
bond to convert trans-vaccenic acid (TVA) (trans18:1) to CLA. Therefore, beef fat is not only an excellent source of CLA, but also contains large
amounts of TVA, which can be converted to CLA in
the human body (Adlof et. al., 2000; Turpeinen et
al., 2001). Moreover, some studies confirmed that
when a diet rich in TVA was fed to humans, mice, or
rats, accumulation of CLA in serum fat or body tissue was detected in a much higher conversion pattern than feeding CLA itself (Salmine et al., 1998;
Santora et al., 2000; Banni et al., 2001). Turpeinen
et al. (2001) showed that the conversion rate over a
range of TVA intakes (1.5, 3, and 4.5 g TVA/day) in
human subjects was 19%, and that interindividual
differences were prominent ranging from one nonresponder to a conversion rate greater than 30% in
another subject. Whether the amount of CLA
formed from TVA in the diet will result in positive

human health benefits remains to be seen. Banni
et al. (2001) showed that the CLA levels formed
from TVA sources reduced the total number of cancer pre malignant lesions by about 50% in rats.
TVA is a trans fatty acid that raises bad cholesterol
in serum (Judd et al., 2002), however, the conversion to CLA is a benefit for human health.
It has been suggested that arachidonic acid
(C20:4) is detrimental to human health (Barham et
al., 2000). However, it promotes inflammation that
is an important protective response when one is
injured. It also forms the basis of anti-inflamatory
prostaglandins that the body uses, to reduce inflammation (Fallon and Enig, 1996). The amount of arachidonic acid in beef is very low (less than 0.5% of
total fat); thus, great amounts of beef have to be
consumed to detect any contradictory effect.
Two other omega-3 fatty acids in beef, DHA
(C22:6) and EPA (C20:5), have been reported to
have health benefits (Mantzioris et al., 2000).
These omega-3 fatty acids have been shown to prevent cancer (Hardman, 2002), and cardiovascular
disease (Simopoulos, 2002), as well as being therapeutic for arthritis (Kremer, 2000), autoimmune disease (Harbige and Fisher, 2001), inflammatory effects (Grimm et al., 2002) and depression (Puri et
al., 2001). DHA is also important during pregnancy
for infant and brain development (Horrocks and
Yeo, 1999; Ewinwright, 2002) and reduces the incidence of premature birth (Allen and Harris, 2002).
EPA lowers blood cholesterol (Pal et al., 2002) and
reduces blood clotting, allowing better blood circulation (Heller et al., 2002). Thus, there is a benefit
from the production of additional DHA and EPA by
the body’s elongation and desaturation of shorter
chain fatty acids (C18:3 omega-3; 18:2 omega-6;
18:1) in humans as mentioned above. There is a lot
of popular discussion about the value of the omega3 fatty acids for human health (Simopoulos and
Robinson, 1999).
Erucic acid (C22:1; about 1%in beef fat) is a fatty
acid that is apparently responsible for a favorable
response of persons with nervous system disorders
(Christensen et al., 1988). The administration of
erucic acid in the diet will reduce the serum levels
and brain accumulation of very long chain saturated
fatty acids (such as C26:0) responsible for demyelination (Sargent et al., 2002; Rasmussen et al.,
2002).
Accumulation of certain long-chain fatty acids is
associated with degenerative diseases of the central nervous system, such as behenic acid (C22:0;
about 1% in beef fat) and lignoceric acid (C24:0;
about 1%) as well as that of the unsaturated mem-

bers of the C22 and C24 group. Accumulation occurs because enzymes needed to maintain turnover
of those fatty acids are lacking (Lord and Braloley,
2001). Behenic acid has been detected to be a
cholesterol-raising saturated fatty acids factor in
humans (Cater and Denke, 2001).
In summary, individual fatty acids have diverse
effects on human health. Heart diseases have
been found to be favorably affected by the consumption of certain unsaturated fatty acids. Unsaturated fatty acids lower plasma total chlolesterol
and “bad” cholesterol levels when substituted for
saturated fatty acids. However, transmonounsaturated fatty acids were found to be intermediate between cis-monounsaturated fatty acid
and long-chain saturated fatty acids in their effects
on plasma total and “bad” cholesterol concentrations. Cholesterol levels are related to cardiovascular diseases. However, predominant beef
fatty acids, such as oleic (C18:1 cis-9) and stearic
(C18:0) appear to be essentially neutral in their effects on cholesterol levels. Moreover, when the effects of lean red meat (beef) vs. lean white meat
(fish, poultry) consumption were compared on the
good and total cholesterol serum levels, no significant difference (P<.001) were present between
treatment groups (Davidson et al., 1999). These
researchers also observed that lean meat was a
more important factor over whether the meat was
white or red. Some of the monounsaturated (C
18:1) fatty acids are important precursors of long
chain fatty acids that are beneficial for human
health. Long-chain omega-3-fatty acids (EPA and
DHA) have an essential role in brain development in
newborns and are vital to the healthy maintenance
and function of the body. They also can help maintain long-term good health by reducing the risk of a
number of diseases such as heart diseases, cancer,
autoimmune diseases, inflammatory diseases, and
depression. Plant fatty acids, such as linoleic acid
(C18:2) and alpha-linolenic acid (C18:3), may be
converted in the ruminant to CLA, which may provide several health benefits in humans relative to
heart diseases, atherosclerosis, cancer, body lipid
content, and immune system. Also beef is a good
source of TVA, which the human body can convert
to CLA. Meat of forage-raised animals contains significantly more omega-3-fatty acids, CLA, and unsaturated fatty acids, compared to meat of animals
finished with stored forages or grain. Thus pasturefinished beef has the potential to compete as a
health-promoting food with other health oriented
products on the market.
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